Bryn Mawr Capital Management LLC Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bryn Mawr Capital Management LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 48.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,085 shares of the medical equipment provider's stock after buying an additional 685 shares during the period. Bryn Mawr Capital Management LLC's holdings in Intuitive Surgical were worth $1,088,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of ISRG. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical in the fourth quarter valued at $82,517,000. Sycomore Asset Management increased its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC grew its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its holdings in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after acquiring an additional 525 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,077 shares of company stock valued at $4,620,025. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Up 1.7 %

NASDAQ ISRG traded up $9.38 during trading hours on Friday, hitting $573.15. The company's stock had a trading volume of 2,399,758 shares, compared to its average volume of 1,733,598. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market capitalization of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The company's 50-day simple moving average is $569.87 and its two-hundred day simple moving average is $528.64.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.